読み込み中
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
前日終値
$6.37
−$0.08 · -1.24%
日中の時刻はETです。市場データは遅延する場合があります。
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
日中レンジ
現在 $6.37
52週レンジ
現在 $6.37
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
76
割安
センチメント
60
まちまち
リスク
70
高リスク
モメンタム
28
弱含み
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
日中レンジ
現在 $6.37
52週レンジ
現在 $6.37
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 5843.5万 USD | 5349.4万 USD | 4216.4万 USD | 3535.8万 USD | 3445.9万 USD |
| 売上原価 | 3131.3万 USD | 2764.3万 USD | 2105.7万 USD | 1540.3万 USD | 1662.6万 USD |
| 粗利益 | 2712.2万 USD | 2585.1万 USD | 2110.7万 USD | 1995.5万 USD | 1783.3万 USD |
| 研究開発 | 562.2万 USD | 532.9万 USD | 613.9万 USD | 1181.4万 USD | 1235.8万 USD |
| 販売・一般管理 | 4515.7万 USD | 2648.8万 USD | 2610万 USD | 2717万 USD | 2388.7万 USD |
| 営業費用 | 5170万 USD | 3651.6万 USD | 3333.6万 USD | 4013.2万 USD | 3748.5万 USD |
| 受取利息 | 9.1万 USD | 10.3万 USD | 8.5万 USD | 1.7万 USD | 3.4万 USD |
| 減価償却費と償却費 | 450.2万 USD | 393.1万 USD | 351.5万 USD | 340.6万 USD | 276.4万 USD |
| 営業利益 | −2457.8万 USD | −1066.5万 USD | −1222.9万 USD | −2017.7万 USD | −1965.2万 USD |
| 純利益 | −3428万 USD | −3140.4万 USD | −1438.3万 USD | −1991.4万 USD | −1960.1万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI231.54万0.00%2.3兆 USD0.03%$381.94+0.63%
Vanguard Extended Market ETFVXF96.06万0.00%954億 USD0.05%$235+0.80%
Dimensional - US Small Cap ETFDFAS25.17万0.00%338.69億 USD0.31%$78.35+0.32%
iShares Micro-Cap ETFIWC19.87万0.02%13.17億 USD0.60%$183+0.11%
Dimensional - US Targeted Value ETFDFAT14.25万0.00%301.22億 USD0.33%$67.27-0.43%
U.S. Micro Cap Portfolio ETFDFMC8.79万0.00%75.58億 USD0.43%$57.813+0.20%
Avantis U.S. Small Cap Equity ETFAVSC6508.05—30.82億 USD0.25%$69.98+0.03%
Dimensional - US Core Equity 2 ETFDFAC4398.90.00%885.96億 USD0.21%$45.33+0.49%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASiShares Micro-Cap ETFIWCDimensional - US Targeted Value ETFDFATU.S. Micro Cap Portfolio ETFDFMCAvantis U.S. Small Cap Equity ETFAVSCDimensional - US Core Equity 2 ETFDFACAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
